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doi:10.1016/j.ejvs.2010.12.021Abstract Objectives: The Mediterranean diet, with a high content of olive oil, is associated
with a reduced risk of coronary artery disease. The aim of this study was to determine the
effect of oleuropein, one of the polyphenols in olive oil, on vascular smooth muscle cell
(SMC) proliferation in vitro.
Design: This was an experimental study.
Materials and methods: Bovine vascular SMCs were cultured in the presence of 100 mM of oleur-
opein. On days 1, 3 and 5, cell number was counted. Cell cycle analysis was performed by flow
cytometry. Cell cycle regulators were assessed by immunoblotting.
Results: Cell proliferation in the presence of oleuropein was significantly inhibited by 92%. Cell
cycle analysis revealed that oleuropein treatment blocked cells in theG1eS phase comparedwith
the non-treated group. AmongG1 phase regulators, retinoblastoma protein, cyclinD, p21 and p27
were not affected by oleuropein, but extracellular signal-regulated kinase 1/2 (ERK1/2) activa-
tion was inhibited. Growth of SMC treated with 100 mM of the mitogen-activated protein (MAP)
kinase/ERK kinase 1 (MEK1) inhibitor PD98059 was also significantly inhibited by 70%.
Conclusions: Oleuropein inhibited SMC proliferation through a cell cycle block between the G1
and the S phases,whichmaybe regulated by ERK1/2. These results suggest amechanismbywhich
olive oil consumption may have beneficial effects on cardiovascular mortality by inhibiting SMC
proliferation.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Despite a high intake of dietary cholesterol and saturated
fat in France, the cardiovascular death rate is one of the
lowest among developed countries. This ‘French paradox’
has been postulated to be related to the high red wine3 785 6217; fax: þ1 203 785 7556
e.edu (B. Sumpio).
ty for Vascular Surgery. Publisheintake in France.1 Among the various components of red
wine, the polyphenols have been postulated to be respon-
sible for the protective effect of red wine in cardiovascular
disease.1,2.
d by Elsevier Ltd. All rights reserved.
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risk of coronary artery disease.3 It has been reported that the
high olive oil consumption in Mediterranean countries can be
correlated to low rates of coronary heart disease mortality.
Recent studies have also emphasised the importance of the
phenolic compounds of olive oil as modulators of key
mechanisms implicated in the development of atheroscle-
rosis.3,4 The major components of olive oil are glycerols,
which represent>98% of total oil weight. Minor components
are present in approximately 2% of oil weight and include
>230 chemical compounds, such as polyphenols.3 The
concentration of polyphenols in red wine is 0.1e15 mg l1.1
Oleuropein, the major polyphenol, is present up to 14% of
total net weight of olive oil polyphenols.5 The aim of this
studywas to determine if oleuropein, an olive oil polyphenol,
could inhibit smooth muscle cell (SMC) proliferation through
its influence on cell cycle regulation.
Methods
SMC cultures
Bovine SMCs were obtained by the aortic explant method
and cultured as previously described.2 Experiments were
conducted on SMC between passages 6 to 10. Oleuropein
(INDOFINE, Hillsborough, NJ, USA) was dissolved in dimethyl
sulphoxide (DMSO) at a stock concentration of 100 mM and
stored at 20 C. We have previously demonstrated that
this dose of DMSO has no effect on SMC proliferation.2
Cell proliferation
SMCs were seeded in 6-well plates and incubated for 24 h at
37 C in a medium containing 10% foetal bovine serum
(FBS). Oleuropein was added after the incubation period to
a final concentration of 100 mM. We performed pilot studies
using 1e100 mM of oleuropein, but only 100 mM showed
consistent inhibitory effect; hence, we used this concen-
tration for the experiments. The control group was SMC
grown without polyphenol exposure. The medium was
changed every 48 h with a new dose of oleuropein added at
that time. On days 1, 3 and 5, cells were harvested by
trypsinisation, and an aliquot was counted with a haemo-
cytometer. The average cell number of three wells was
calculated for each experiment.
To examine the reversibility of SMC growth inhibition me-
diated by the phenolic compounds, SMCs were seeded, incu-
bated and initially exposed to 100 mM of oleuropein, as
described earlier. After 1 day of phenol exposure, themedium
was changed without any oleuropein being added, and
subsequentmediumchangeswere spacedat48h intervals.On
days 1, 3 and 5, cells were harvested by trypsinisation, and an
aliquot was counted with a haemocytometer.
Cell cycle analysis
SMCs were incubated with 10% FBS medium for 24 h at 37 C
and synchronised with serum-free medium (SFM) for 24 h.
Oleuropein was added after the incubation period to a
final concentration of 100 mM. On days 1 and 5, SMCs
were trypsinised, and subjected to cell cycle analysis aspreviously described,2 using flow cytometry (BD FACSCali-
bur, Department of Laboratory Medicine, Yale University)
analysed with a FlowJo software.
Western blot analysis
SMCs were seeded in 6-well plates, incubated with 10% FBS
medium for 24 h at 37 C and then placed in SFM for 24 h. In
parallel experiments, cells were then exposed to 10% FBS
medium with or without 100 mM of oleuropein added, for
15 min to 24 h. After experimentation, SMCs were prepared
for immunoblotting, as previously described.2 In brief, cell
lysates containing 15 mg proteins were loaded in each lane
and separated in 10% TriseHCl gels (Bio-Rad) and then
transferred to a polyvinylidene fluoride (PVDF) membrane
(Millipore, Billerica, MA, USA). The membranes were incu-
bated with anti-phospho-retinoblastoma protein (Rb) anti-
body (Ab), anti-total-Rb Ab, anti-cyclinD Ab, anti-p21 Ab,
anti-p27 Ab, anti-phospho-extracellular signal-regulated
kinase (ERK) 1/2 Ab and anti-total-ERK1/2 Ab (Cell Signaling
Technology, Danvers, MA, USA) in a 5% milk Tris-buffered
saline with Tween-20 (TBS-T) blocking solution. Band
densities were measured with Image J software (National
Institutes of Health). Band densities were normalised
against the control lane (untreated cells).
Inhibitor studies
Cell proliferation, cell cycle analysis and Western blot
analysis were performed as described above, in the pres-
ence of the mitogen-activated protein (MAP) kinase/ERK
kinase 1 (MEK1) inhibitor PD98059 (Promega Corporation,
Madison, WI, USA) instead of oleuropein. PD98059 was also
dissolved in DMSO.
Statistics
Data are expressed as mean  standard deviation (SD).
Results from the proliferation study were statistically
evaluated by one-way analysis of variance (ANOVA) fol-
lowed by a Bonferroni post hoc test using Statistical
Package for Social Sciences (SPSS) version 16.0 (SPSS Inc,
Chicago, IL, USA). Pearson’s chi-square test was used to
analyse data from the cell cycle analysis. P < 0.05 was
considered significant.
Results
Oleuropein inhibited SMC proliferation in a dose-
dependent but reversible manner
Pilot studies showed that 10 mM of oleuropein partially, but
significantly, inhibited SMC proliferation by 39% (data not
shown). Fig. 1 demonstrates that SMC proliferation was
completely inhibited in the presence of 100 mM of oleur-
opein compared with controls. Although the growth of cells
exposed to oleuropein for 5 days was inhibited, phenol
removal on day 1 resulted in cell recovery to a normal
growth pattern by day 3 that was indistinguishable from
control cells (Fig. 1). There was no evident gross morpho-
logical change in SMC exposed to oleuropein.
Figure 1 Growth inhibition induced by oleuropein. SMC were exposed to 100 mM of oleuropein for 5 days or SMC were exposed to
100 mM of oleuropein for one day and then grown without oleuropein to determine reversibility. A) Cell growth curve for a typical
experiment. The x-axis represents the time course of the experiment, and the y-axis represents the cell number per well.
)p < 0.05 compared with control on day 5. There was significant inhibition (by 92%) of SMC growth in the presence of oleuropein.
Experiments were repeated in triplicate. B) Light power microscopy for SMC with and without oleuropein  100 magnification.
C) Oleuropein was removed on day1. Cell growth inhibition could be reversed by removing the polyphenol.
816 R. Abe et al.Oleuropein induced a block between the G1 and S
phases of the cell cycle
Cell cycle analysis using propidium iodide was performed on
SMCs treated with 100 mM oleuropein for 1 or 5 days. On day
1, in the control group, cell population in the G1 phase was47.5% and that in the S phase was 44.2%. The cell pop-
ulation of the oleuropein group in the G1 phase was 75.8%
and that in the S phase was 14.4%. There was a significant
increase in oleuropein-treated cells in the G1 phase
compared with control cells, with a corresponding signifi-
cant decrease of S phase cells. This demonstrates a block
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control (Fig. 2). There was no significant difference
between the oleuropein-treated group and the control
group on day 5.
Oleuropein inhibited ERK1/2 phosphorylation
We assessed several proteins, which are known to regulate
the cell cycle between the G1 and the S phases.6e9 Fig. 3
indicates that phospho-Rb, cyclinD and p27 immunoblots
demonstrated no difference between the controls and the
cells treated with 100 mM of oleuropein. No band for p21
could be obtained for either group. Fig. 3 also shows that
ERK1/2 phosphorylation was evident by 15 min in the
control cells, peaked by 30 min and then slowly dis-
appeared; 100 mM of oleuropein inhibited ERK1/2 phos-
phorylation significantly compared with the control group
(Fig. 3).
PD98059 inhibited SMC proliferation
Pilot studies indicated that SMC grown in the presence of
the MEK inhibitor PD98059 at 10 mM concentration was
partially inhibited by 24% (data not shown). At 100 mM
concentration, SMCs were significantly inhibited after 5
days of exposure (Fig. 4). However, after removal of the
inhibitor on day 1, the cells recovered to their normal
growth pattern that was only slightly different from the
control cells (Fig. 4). The cells treated with PD98059
showed reversibility similar to the cells treated with
oleuropein.Figure 2 A) Representative flow cytometric histograms of SMC in t
in histograms represents the number of cells which are in the G0-1
(mitosis, third curve), phase of the cell cycle. Experiments were re
SMC in various phases of the cell cycle. )p < 0.05 compared withDiscussion
Though the Mediterranean diet varies somewhat regionally,
its nutritional model of whole grains, vegetables, fruits, red
wine and olive oil is believed to contribute to decreased
rates of coronary heart disease.3 Oleic acid is a major
component of olive oil, and is primarily responsible for the
Mediterranean diet being high in monounsaturated fatty
acids (MUFAs) and low in saturated fatty acids (SFAs)3 that
may play a role in preventing the development of ather-
omas and subsequent thrombi.3 Phenolic compounds, the
minor constituents of olive oil, also have substantial
vascular and cardioprotective effects.10 To our knowledge,
the current study is the first to demonstrate that oleur-
opein, the predominant polyphenol in olive oil, could
inhibit proliferation of vascular SMC.
Resveratrol and oleuropein have been widely studied in
tumour cells and are being increasingly recognised as
cancer chemotherapeutic agents, based on their properties
as antioxidants and as antimutagenic agents.1117 Although
these polyphenols have been reported to inhibit prolifera-
tion of several cancer cell lines, there are only few studies
on vascular SMC. We have previously reported that resver-
atrol inhibits SMC proliferation, but the mechanism was not
completely elucidated.2 In this study, we demonstrated
that 100 mM oleuropein could inhibit SMC proliferation
through a block of the cell cycle that may be mediated
through inhibition of ERK1/2 activity. The inhibition was
dose-dependent, as our pilot studies showed that 10 mM
oleuropein led to a partial inhibition. This inhibition was
also reversible, as Fig. 1 shows that removal of oleuropeinhe absence or presence of oleuropein for 1 or 5 days. The y-axis
(growth, first curve), S (DNA synthesis, second curve), or G2eM
peated in duplicate. B) Bar graph representation of percent of
control by Pearson’s chi-square test.
Figure 3 Immunoblot for phospho/total-ERK1/2, phospho/total-Rb, cyclinD, p27, and p21 of SMC in the absence or presence of
100 mM oleuropein. C: control, O: oleuropein-treated group.
818 R. Abe et al.on day 1 resulted in a resumption of SMC proliferation. This
latter outcome strongly suggests that the effect of oleur-
opein is not due to cell toxicity. Furthermore, there were
no gross morphological changes that we could detect.
Lastly, trypan blue exclusion studies that were performed
in pilot studies also confirmed the lack of any significant
toxicity by oleuropein.
Our result suggests that inhibition of SMC proliferation
by oleuropein was the result of a cell cycle block between
the G1 and the S phases. Interference with the cell cycle
has been previously reported with other polyphenols.
Although the reports uniformly suggest an arrest of cell
progression before the M phase, the precise location of the
block is not clear, with different papers indicating either
a G1eS or SeG2 phase block, depending on the cell type
studied.18,19 There is only a single report about oleuropein
and its effect on the cell cycle, in which oleuropein resul-
ted in a G1eS block in breast cancer MCF-7 cells.13 It is
interesting that in our study there was no difference in cell
cycle distribution between the oleuropein group and the
control group on day 5. The reason for this finding is not
clear. Further studies will be required to delineate this
phenomenon.
We also postulated that because the SMC cell cycle was
blocked between the G1 and the S phases in our study,
oleuropein could be interfering with the cell cycle regu-
lators in the G1 phase. There are many proteins, such as
Rb, cyclins, cyclin-dependent kinases (CDKs), CDK inhibi-
tors (p21, p27 and p57) and p53, which are known to
control the cell cycle at the G1 phase. The cyclin/CDK
complex can effect cell cycle progression through pRb-
dependent entry into the S phase and, hence, assessment
of phosphorylation of Rb is a good barometer of the familyof cyclins, CDKs, CDK inhibitors and p53.2023 In our study,
we first evaluated the phosphorylation of Rb and demon-
strated that it was not affected by oleuropein. This latter
result might be sufficient, but we decided to confirm this
by assessing cyclinD, p21 and p27, which were reported to
be affected by oleuropein in cancer cells. ERK1/2 is the
other major regulator of the G1 phase and has been
recently reported to be affected by oleuropein.24 ERK1/2
plays a role in the G1 phase not only through pRb-depen-
dent entry, but also through other pathways, although the
exact details have not been clarified. Fig. 3 shows that
activation of Rb, cyclinD, p21 and p27 were not affected by
oleuropein, but ERK1/2 activation was significantly
inhibited. Resveratrol has been reported to increase the
level of inhibitors p53, p21 and p27 when added to
different cancer cell lines.25 Resveratrol has also been
demonstrated to decrease the phosphorylation of Rb and
the level of cyclins and CDKs.12,14,16,26e28 On the other
hand, there is only scant information on the effect of
oleuropein on cell cycle regulators. We could find only one
article that showed the effect of oleuropein on the G1
phase of the cell cycle. This report demonstrated that
oleuropein inhibits MCF-7 breast cancer cell proliferation
by interfering with ERK1/2 activation, similar to the effect
we observed in our study.24
To further delineate the association of oleuropein
inhibition of SMC proliferation and oleuropein inhibition of
ERK1/2 activity, we confirmed that the MEK1 inhibitor
PD98059 could inhibit SMC ERK1/2 activity (data not
shown) and SMC proliferation (Fig. 4). The concentration
of PD98059 of 100 mM that we used is high but we found in
our pilot studies that PD98059 at the concentration of
10 mM did not inhibit ERK1/2 activity completely (data not
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Figure 4 Growth inhibition induced by PD98059. SMCs were exposed to 100 mM of PD98059 for 5 days or SMCs were exposed to
100 mM of PD98059 for one day and then grown without PD98059. The x-axis represents the time course of the experiment, and the
y-axis represents the cell number per well. )p < 0.05 compared with control on day 5. Experiments performed in duplicated. A)
Cell growth curve for a typical experiment. B) PD98059 was removed on day 1. Cell growth inhibition could be reversed by removing
the PD98059.
Oleuropein Inhibits SMC Proliferation 819shown), and had only approximately 25% inhibition of SMC
proliferation. Fig. 4 demonstrates that removal of PD98059
from the media caused recovery of SMC proliferation later
than day 3. By contrast, Fig. 1 shows that oleuropein
removal from the media resulted in cell recovery to
a normal growth pattern by day 3 that was indistinguish-
able from control. The later recovery of SMC proliferation
seen in Fig. 4 is not clear, but could represent different
rates of cell removal of PD98059 and oleuropein or even
their different inhibition of MEK1. Taken as whole,
however, our data are consistent with the hypothesis that
oleuropein inhibits ERK1/2 activity, which then leads to
a decrease in SMC proliferation.
The absorption of ingested olive oil phenols is estimated
to be at least 55e66% of the ingested dose in humans,29
although total plasma concentration after consumption in
humans has not been clarified. Del Boccio et al. reported
that after 100 mg kg1 of oleuropein was administered in
a single dose in a rat, they could detect 137 ng ml1 of
oleuropein in plasma.30 Theoretically, for a 70 kg person,
100 mM of oleuropein would correspond to an intake of more
than 2 kg of oleuropein, if all absorbed oleuropein
appeared in plasma. It has been estimated that inhabitants
of Mediterranean countries ingest 30e50 g of olive oil per
day.31 As extra virgin olive oil contains 15 mg kg1 of
oleuropein as oleuropein-aglycone;13 this corresponds to
0.45e0.75 mg of oleuropein per day. Although the amountof olive oil consumed in Mediterranean countries is much
less than that in our short-term experimental studies, daily
ingestion of olive oil could have cumulative effects over the
human life span. Nonetheless, the dose of 100 mM oleur-
opein that we used in our experiments is similar to that of
previous in vitro studies, where up to 370 mM concentration
was used.13,17,24,32
In summary, our results demonstrate that oleuropein
inhibits SMC proliferation through a cell cycle block, which
may be regulated by ERK1/2. These results suggest one of
the mechanisms by which the Mediterranean diet may have
beneficial effects on cardiovascular mortality. This effect
of oleuropein on atherogenesis may not only be limited to
an anti-proliferative effect but may also include other
actions. Oleuropein has also been shown to inhibit platelet
aggregation,33 increase high-density lipoprotein and
decrease low-density lipoprotein oxidation.34 Thus,
a connection between olive oil polyphenols and their anti-
atherogenic effect is likely.
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